CRISPR Therapeutics AG (CRSP) EBIT Margin (2016 - 2026)
CRISPR Therapeutics AG (CRSP) reported EBIT Margin of -1026.48% for Q3 2026, up 13828.30 percentage points from -14854.78% a year earlier and up 125.36 percentage points from the prior quarter.
CRISPR Therapeutics AG (CRSP) EBIT Margin (2016 - 2026) Analysis & Trends
Over the twelve months ended Sep 30, 2026, CRISPR Therapeutics AG's EBIT Margin came in at -2114.75%, down 616.48 percentage points year-over-year; for FY2025, it was -18933.65%, down 17683.27 percentage points from FY2024.
- EBIT Margin has a five-year change of +30361.90 percentage points (FY2020 to FY2025).
- By year, EBIT Margin came in at -1250.38% in FY2024 (-1190.43 pp), -59.95% in FY2023 (+56130.45 pp), -56190.40% in FY2022 (-56231.23 pp) and 40.82% in FY2021 (+49336.37 pp).
- The Q3 2026 figure ranks as the highest quarterly EBIT Margin since Q4 2024.
- Year over year, EBIT Margin has now increased in each of the last three quarters, with an average year-over-year change of +5798.35 percentage points over the last eight quarters.
- The high point for year-over-year EBIT Margin in five years was Q4 2023 (a gain of 2192384.58 percentage points); the low point was Q4 2022 (a drop of 2191220.47 percentage points).
- Per Business Quant data, the three quarters before Q3 2026 came in at -1151.84% (Q2 2026), -8933.33% (Q1 2026) and -17912.50% (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 52.42% |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 24.35% |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 36.01% |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 30.89% |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 35.79% |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 41.71% |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 32.98% |
| 10 | CRISPR Therapeutics AG | 4.65 Bn | -4.41 Bn | - | -1,026.48% |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -1,026.48% |
| Jun 30, 2026 | -1,151.84% |
| Mar 31, 2026 | -8,933.33% |
| Dec 31, 2025 | -17,912.50% |
| Sep 30, 2025 | -14,854.78% |
| Jun 30, 2025 | -25,708.97% |
| Mar 31, 2025 | -17,158.84% |
| Dec 31, 2024 | -180.96% |
| Sep 30, 2024 | -18,294.02% |
| Jun 30, 2024 | -29,257.25% |
| Mar 31, 2024 | -27,894.25% |
| Dec 31, 2023 | 34.58% |
| Jun 30, 2023 | -136.03% |
| Mar 31, 2023 | -64.49% |
| Dec 31, 2022 | -2,192,350.00% |
| Sep 30, 2022 | -194,029.79% |
| Jun 30, 2022 | -115,987.34% |
| Mar 31, 2022 | -18,720.43% |
| Dec 31, 2021 | -1,129.53% |
| Sep 30, 2021 | -15,637.01% |
CRISPR Therapeutics AG EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=CRSP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "CRSP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=CRSP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();